Kappadione
From Wikipedia, the free encyclopedia
 |
|
|
Kappadione
|
|
| Systematic (IUPAC) name | |
| tetrasodium (2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate hexahydrate | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C12H20O14P2 |
| Mol. mass | 530.174702 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Rx-only, Discontinued (Was FDA Approved) |
| Routes | Injection |
Kappadione is a Vitamin K derivative. It was manufactured by Eli Lilly and Company.[1] It is also known as Menadiol sodium diphosphate.
[edit] References
- ^ Kappadione overview, medicine.org. Retrieved on 2008-04-14.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
